First-in-Human Study of Orally Administered GS-441524 for COVID-19
- First Posted Date
- 2021-04-26
- Last Posted Date
- 2021-08-10
- Lead Sponsor
- Copycat Sciences LLC
- Target Recruit Count
- 1
- Registration Number
- NCT04859244
- Locations
- 🇺🇸
Copycat Sciences Study Site, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath